NCT03504644 2026-02-25
Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia
Eastern Cooperative Oncology Group
Phase 1/2 Active not recruiting
Clinical Trials
1 trialsPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma × Magnetic Resonance Spectroscopy × 30 days × Clear all